These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14174038)

  • 21. POTENTIAL ANTICANCER AGENTS. LXXX. ALKYLATING AGENTS RELATED TO PHENYLALANINE MUSTARD. VI. ENANTIOMERIC META-PHENYLALANINE MUSTARDS.
    GRAM HF; BERRIDGE BJ; ACTON EM; GOODMAN L
    J Med Chem; 1963 Jan; 6():85-7. PubMed ID: 14174040
    [No Abstract]   [Full Text] [Related]  

  • 22. SYNTHESIS OF N,N-BIS(2-CHLOROETHYL)-DL-PHENYLALANINE HYDROCHLORIDE.
    LEE WW; TONG GL; MARTINEZ AP; WEINSTEIN B; SCHELSTRAETE MG; BAKER BR; GOODMAN L
    J Med Chem; 1963 Jul; 6():439-42. PubMed ID: 14191388
    [No Abstract]   [Full Text] [Related]  

  • 23. SYNTHESIS OF POSSIBLE CANCER CHEMOTHERAPEUTIC COMPOUNDS BASED ON ENZYME APPROACH. V. TETRAZOLIUM NITROGEN MUSTARDS.
    TSOU KC; SU HC
    J Med Chem; 1963 Nov; 6():693-6. PubMed ID: 14184928
    [No Abstract]   [Full Text] [Related]  

  • 24. EXPERIMENTAL RESULTS OF NEW ANTICANCER DRUG-PHENESTERIN.
    DEGTEVA SA
    Acta Unio Int Contra Cancrum; 1964; 20():153-6. PubMed ID: 14151873
    [No Abstract]   [Full Text] [Related]  

  • 25. Potential carcinolytic agents. V. Enamine mustards.
    Papanastassiou ZB; Bruni RJ; White E
    J Med Chem; 1967 Jul; 10(4):701-6. PubMed ID: 6037064
    [No Abstract]   [Full Text] [Related]  

  • 26. NITROGEN MUSTARD-RESISTANT YOSHIDA SARCOMA AND CROSS-RESISTANCE STUDIES.
    UJHAZY V; WINKLER A
    Neoplasma; 1965; 12():11-4. PubMed ID: 14278323
    [No Abstract]   [Full Text] [Related]  

  • 27. EFFECTS OF URACIL MUSTARD ON INCORPORATION OF L-LYSINE-U-14C INTO ACIDIC NUCLEOLAR PROTEINS OF THE WALKER TUMOR AND LIVER.
    DESJARDINS R; BUSCH H
    Tex Rep Biol Med; 1964; 22():444-53. PubMed ID: 14221508
    [No Abstract]   [Full Text] [Related]  

  • 28. POTENTIAL CARCINOLYTIC AGENTS. I. DERIVATIVES OF P,P-BIS(1-AZIRIDINYL)PHOSPHINIC AMIDE.
    FRIEDMAN OM; LEVI RS; PAPANASTASSIOU ZB; WHALEY WM
    J Med Chem; 1963 Jul; 6():449-50. PubMed ID: 14184905
    [No Abstract]   [Full Text] [Related]  

  • 29. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS.
    BOYLAND E; KINDER CH; WILLIAMS K
    Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785
    [No Abstract]   [Full Text] [Related]  

  • 30. THE EFFECTS OF FIBRIN FORMATION AND ALTERATIONS IN THE CLOTTING MECHANISM ON THE DEVELOPMENT OF METASTASES.
    CLIFFTON EE; AGOSTINO D
    Vasc Dis; 1965 Jan; 2():43-52. PubMed ID: 14252944
    [No Abstract]   [Full Text] [Related]  

  • 31. Potential carcinolytic agents. 3. Fluoronitrogen mustard analogs of cyclophosphamide.
    Papanastassiou ZB; Bruni RJ; Fernandes FP; Levins PL
    J Med Chem; 1966 May; 9(3):357-9. PubMed ID: 5960905
    [No Abstract]   [Full Text] [Related]  

  • 32. N-(2-chloroethyl)-N-(2-hydroxyethyl)arylamines. Possible intermediates to potential carcinolytic agents bearing dissimilar reactive functions.
    Foster AB; Jarman M; Ross WC; Tisdale MJ
    J Med Chem; 1972 Aug; 15(8):869-70. PubMed ID: 5044312
    [No Abstract]   [Full Text] [Related]  

  • 33. PRECLINICAL STUDIES FOR THE CHARACTERISATION OF NEW ANTICANCER AGENTS IN ANIMAL EXPERIMENTS.
    BROCK N
    Acta Unio Int Contra Cancrum; 1964; 20():45-7. PubMed ID: 14151959
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
    Norpoth K; Witting U; Rauen HM
    Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
    [No Abstract]   [Full Text] [Related]  

  • 35. INTERACTION BETWEEN 5-HYDROXYTRYPTAMINE AND ANTITUMOURAL DRUGS.
    PALMA V; REYERS-DEGLIINNOCENTI I; GARATTINI S
    J Pharm Pharmacol; 1964 Nov; 16():770-1. PubMed ID: 14241150
    [No Abstract]   [Full Text] [Related]  

  • 36. [CYCLOPHOSPHANE, ETHOXENE AND THIO-TEPA IN THE PREVENTION OF METASTASES FOLLOWING SURGICAL EXTIRPATION OF TRANSPLANTED TUMORS].
    GRIGALINOVICH GA; ZIDERMANE AA; ZHAGATA MA
    Klin Lech Zlokach Novoobraz; 1963; 92():157-60. PubMed ID: 14182294
    [No Abstract]   [Full Text] [Related]  

  • 37. [RESEARCH ON THE ANTIBLASTIC ACTION OF A NITROGEN MUSTARD OF THE URETHANE TYPE BOUND TO HYDROCORTISONE].
    ZIMEL H; MACRINEANU A
    Stud Cercet Endocrinol; 1964; 15():413-8. PubMed ID: 14241419
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental animal studies on the regional perfusion of tumors of the extremities].
    Brock N; Niekamp T
    Arzneimittelforschung; 1968 Jan; 18(1):1-7. PubMed ID: 5754938
    [No Abstract]   [Full Text] [Related]  

  • 39. [TEST OF THE ACTION OF SOME NITROGEN MUSTARD DERIVATIVES ON STICKER'S LYMPHOSARCOMA].
    ZEZZANETO L; SOERENSEN B; SALIBA AM; GRECCHI R
    Rev Bras Cir; 1963 Aug; 46():101-8. PubMed ID: 14097899
    [No Abstract]   [Full Text] [Related]  

  • 40. [EXPERIMENTAL STUDIES ON CARCINOMA AND ITS ARRESTED STATE. 9. PHARMACOLOGY OF URACIL MUSTARD, A CHEMOTHERAPEUTIC ANTINEOPLASTIC AGENT].
    CHANG M
    Nihon Yakurigaku Zasshi; 1964 Sep; 60():413-34. PubMed ID: 14271233
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.